Skye Bioscience (SKYE) Announces $50 25M Private Placement streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Skye Bioscience, Inc. , a clinical stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid.
Skye Bioscience, Inc. , a pharmaceutical company developing drugs targeting the endocannabinoid system, has received clearance of its Investigational New Drug application with the U.S. Food and Drug.
Skye Bioscience has announced its plans to develop nimacimab, the company’s monoclonal antibody recently acquired from Bird Rock Bio, for weight loss and the treatment of obesity.